Brian Ting

@TulaneMedicine. Views are mine, if any.

[Duke GI @Duke_GI_]

Proud to celebrate Dr. Matt Kappus🌟
His leadership & work thru the Duke Clinical Leadership Program on understanding perspectives in living donor vs DCD liver transplantation shape the future of patient‑centered transplant care.
More stories like this ➜ https://t.co/nR5bGK3M19

[Ruben Hernaez @ruben_hernaez]

Not all patients of aki has HRS, only 1/3 and use HRS criteria

[The Osler Medical Residency @OslerResidency]

Fantastic @JohnsHopkinsDOM grand rounds today-debate on CRC screening including former Barker/firm of choice resident and now esteemed pjysician scientist in GI #zacharyfoda and moderated by former Firm of Giants and Ambo/Stevens ACS @lindsaycsheets 💪🏽🙌🏽 #oslerpride

[Mariam Naveed, MD @MN_GIMD]

Amazing kickoff to @AmCollegeGastro #2ndYFC with @DHassMD discussing “Life After Fellowship”

Some pearls from the talk:

⭐️ Define your practice goals early.
⭐️Setting and culture matter as much as pay.
⭐️Ask how work is distributed and how success is measured.
⭐️Fit > prestige. Long-term satisfaction comes from alignment.
⭐️Use your network. Most jobs come from people, not postings.
⭐️See volume and variation in fellowship. It shapes your judgment.
⭐️Learn from many, then build your own clinical style.
⭐️Non-clinical skills matter. Billing, QI, EMR, leadership compound.
⭐️Know billing and coding before you graduate. It protects autonomy.

[Brian Ting @HepaTing]

Proud of you @sychan0514 ! @AASLDtweets

[Emily Shu-Yen Chan, MD, MSc @sychan0514]

Feeling so grateful to be part of the #ELS family and to connect with many inspiring, passionate peers at #TLM2025! Big thanks to my amazing mentor @HepaTing 🤩🙏
@AASLdtweets

[Yee Hui Yeo @YeeHuiYeo1]

Breaking: Psychiatric issues in ALD patients reduce treatment success & up relapse risks!

Over the 10 yrs, certain psych conditions exploded in ALDs, but not all! Which ones? Why the surge?

Fresh nationwide study drops JUST before #TLM2025
Check it out! https://t.co/Vhzi0gQesp
#MentalHealth @AASLDtweets @AASLDFoundation @OpenlySober

[Liver Fellow Network @LiverFellow]

⭐️ Step into your future in GI & Hepatology ⭐️

Applying to GI this cycle and interested in Hepatology?

Join us for a webinar with fellows & program directors sharing practical insights on preparing for fellowship

🎯 Register here: https://t.co/gHYzX99V4s

@AASLDtweets

[Brian Ting @HepaTing]

So proud of you @sychan0514 !

[AASLD Foundation @AASLDFoundation]

👏 Big congratulations to these 2025 #AASLDFoundation #EmergingLiverScholars!

🌟Gurmehr Brar @KeckMedUSC
🌟Yueming Cao @YNHH
🌟@norinewchan @DukeMedSchool
🌟@sychan0514 @WeissHospital

View the full list:: https://t.co/spYSpZhaBl

[AASLD Foundation @AASLDFoundation]

👏 Big congratulations to these 2025 #AASLDFoundation #EmergingLiverScholars!

🌟Gurmehr Brar @KeckMedUSC
🌟Yueming Cao @YNHH
🌟@norinewchan @DukeMedSchool
🌟@sychan0514 @WeissHospital

View the full list:: https://t.co/spYSpZhaBl

[Yee Hui Yeo @YeeHuiYeo1]

👎We’re failing patients with alcohol-associated liver disease

🏥 ALD admissions: 11.5k → 37.5k (2014–2023)

Among ALD admissions, within 1 year post-discharge:
💊 Medication rates barely reached 24%
🧠 Any psychiatric visit remained at 6.5% in 2023!!!
👥 Sex disparity: post-DC care was worse in males

Sobering gap in postdischarge support, we MUST do better! @JAMANetworkOpen @AlcoholPolicy @AASLDtweets @AlcoholFocus @AlcoholChangeUK @NIAAAnews @ASAMorg @samhsagov @HepaTing @sychan0514 @juanpabloarab @rabataller

[Brian Ting @HepaTing]

@sychan0514 great work Emily! Rising alcohol relapse prevention therapy initiation after admission for alcohol related liver disease may be a concerted effort by the medical community to curb adverse effects of alcohol use, but remains so for a minority of patients.

[JAMA Network Open @JAMANetworkOpen]

This study found underutilization of post-discharge pharmacological and psychiatric interventions for alcohol relapse prevention therapy. https://t.co/lcmoBb64av @hepating @YeeHuiYeo1

[JAMA Network Open @JAMANetworkOpen]

This study found underutilization of post-discharge pharmacological and psychiatric interventions for alcohol relapse prevention therapy. https://t.co/lcmoBb64av @hepating @YeeHuiYeo1

[Elliot Tapper @ebtapper]

There are two ways to meet an expert IBD-ologist

One, attend @GuildConference
Two, which is what I do most of the time, say out loud "Ulcerative colitis? Let's start cipro/flagyl!" or "Crohn's? Time for mesalamine". Usually they come running straight to you

[Dr.Bornie @Apichatka]

@sychan0514 @HepaTing @YeeHuiYeo1 🥇

[Brian Ting @HepaTing]

@MichelleMaMD @Jpah @HopkinsGIHep @OslerResidency Classic

[Tulane - Department of Surgery @Tulane_Surgery]

Did you tune in to catch Dr. Hoonbae Jeon on @fox8nola this morning? Dr. Jeon shared exciting details about the Tulane Transplant Institute's new location at East Jefferson General Hospital! 🏥 #tulanetransplant #tulanesurgery

[HEPATOLOGY Journal @HEP_Journal]

Huang DQ, Tran A et al. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
#LiverTwitter
https://t.co/A5LyJHA7Wq

[James Hamilton @JPAHamiltonMD]

Great night celebrating Johns Hopkins Hepatology @AASLDtweets @HopkinsGIHep @OslerResidency

[Brian Ting @HepaTing]

Reunited to make the liver whole again, my cofellow @alystraussMD #TLM22

[Michelle Ma MD @MichelleMaMD]

Congrats to our graduating @HopkinsGIHep fellows of 2022! Being your APD has been the highlight of my academic year. We are so proud of you!!
@ChrisFanMD @alystraussMD @SunnyOhSon @HepaTing @tworeta1 @JoannaMeliaMD @DrKohli @SNgamruengphong
@HopkinsMedicine @OslerResidency